law-firm-pomerantz-investigates-tibet-pharma-statements

Investors eye Japan's pharma law reformation

  • Japan
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Assuming the role of Prime Minister of Japan in December 2012, Mr Shinzo Abe has provided a boon for Japanese biotechnology stocks, with half of the top... Read more

ms-nan-wang-is-the-new-cfo-of-sinovac-biotech

Reverse Medical announces alliance in Japan

  • Japan
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Reverse Medical announced entering into a strategic partnership agreement with Century Medical (CMI), for distribution of the Reverse Medical products... Read more

university-of-california-san-francisco-study-women-who-get-less-than-six-hours-of-sleep-every-night-are-at-a-greater-risk-of-inflammation-and-thus-heart-attacks

Women who sleep less than 6hrs may get heart attacks

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: A new study by University of California, San Francisco, US, (UCSF) has revealed that women who get less than six hours of sleep every night are at a greater... Read more

bad-news-for-flu-virus-sanofi-pasteur-s-fluzone-quadrivalent-flu-vaccine-gets-us-fda-nod

FDA nod for Sanofi quadrivalent flu vaccine

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: The US FDA has approved Sanofi Pasteur supplemental biologics license application (sBLA) for its four-strain influenza vaccine, Fluzone Quadrivalent,... Read more

smoking-near-pet

Pets of smokers are twice as likely to get cancer

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: While health alerts issued about the dangers of passive smoking elaborate the harm that being exposed to tobacco smoke can cause in humans, seldom do... Read more

ema-chmp-gives-marketing-authorization-for-teva-pharmaceutical-s-neutropenia-drug-lonquex-xm22-lipegfilgrastim-in-eu

Teva's Lonquex gets EU market authorization

  • Europe
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: European Medical Association's (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended that a marketing authorization may be issued... Read more

traveller-s-stomach

Tourists to soon get vaccine for 'Delhi Belly', typhoid...

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Researchers at the University of Cambridge, UK, are developing a vaccine that would prevent bad stomach (or Delhi Belly as it is popularly called) or... Read more

valneva-is-selling-its-clinical-manufacturing-operations-cmo-in-nantes-france-to-biological-e

India's Biological E to buy French Valneva's CMO unit

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: France-based biotech firm Valneva is selling its clinical manufacturing operations (CMO) in Nantes to India-based Biological E. The sale of this unit,... Read more

mounting-debts-and-fierce-competition-forces-elder-pharmaceuticals-to-start-looking-for-buyers

Deep in debt Elder Pharma decides to sell itself

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: India-based Elder Pharmaceuticals is said to be up for sale, according to a report published in the Economic Times. The news of the sale of the firm,... Read more

french-police-probe-the-death-of-a-man-found-with-opened-packages-of-teva-s-diuretic-furosemide

French cops probe 'death' after Teva drug alert

  • Europe
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Merely two days after France's drug regulator, ANSM, asked pharmacies and consumers there to return almost 190,000 boxes of Teva Pharma's diuretic, furosemide,... Read more

orion-health-to-integrate-its-electronic-health-records-ehr-solution-with-the-caradigm-intelligence-platform-cip

MMR, UNIS join hands with Chinese government

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: MMRGlobal announced that through its China joint venture, Unis-Tonghe MMR International Health Management Service, with JV partner Unis-Tonghe Technology... Read more

vela-diagnostics-pcr-based-research-use-only-will-identify-new-strain-of-bird-flu-h7n9-and-coronavirus-hcov-emc

Vela develops genetic tests for H7N9 bird flu

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Vela Diagnostics has launched PCR-based Research-Use-Only (RUO) tests for the identification of genetic targets specific to a new strain of bird flu (H7N9),... Read more

sgs-expands-services-towards-biologics-testing

Samsung forays into medtech market in India

  • India
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Samsung India strengthened its presence in the health and medical equipment business in the country by launching digital radiology and in-vitro diagnostics equipment... Read more

bayer-healthcare-s-gideon-global-investigation-of-therapeutic-decisions-in-hepatocellular-carcinoma-and-of-its-treatment-with-sorafenib-study-progressed-with-positive-data-in-phase-iii-trial

Bayer progresses on APAC hepatocellular carcinoma trial...

  • Singapore
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: GIDEON (Global Investigation of therapeutic Decisions in hepatocellular carcinoma and of its treatment with sorafenib) study by Bayer HealthCare, a global... Read more

biotechnology-industry-organization-and-delaware-bioscience-association-delaware-bio-commended-delaware-state-senate-us-for-introducing-legislation-addressing-interchangeability-of-biological-medicines

New US biosimilars legislation gets commendation

  • US
  • |
  • Regulatory
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Biotechnology Industry Organization and Delaware BioScience Association (Delaware Bio) have commended Delaware State Senate, US, for introducing legislation... Read more

Special Features

Survey Box

Ranbaxy Controversy

Will the Ranbaxy controversy end the Indian pharma dominion in the US market?

Send this article by email

X